Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUPROPION vs BUPROPION\NALTREXONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUPROPION vs BUPROPION\NALTREXONE: Safety Overview

Metric BUPROPION BUPROPION\NALTREXONE
Total FAERS Reports 35,634 7,763
Deaths Reported 8,577 30
Death Rate 24.1% 0.4%
Hospitalizations 10,246 628
Average Patient Age 44.6 yrs 50.0 yrs
% Female Patients 70.7% 87.6%
FDA Approval Date Apr 12, 2017 N/A
Manufacturer NuCare Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A